GlassScriptPhysician profile
Kaveh Akhbari
NPI 1144541764
$6,716.86
in general payments reported to CMS, 2019-2025
18 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,276 · 2020: $694 · 2021: $1,088 · 2022: $1,032 · 2023: $1,010 · 2024: $1,127 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.79 |
| Travel and Lodging | $258.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,526.17 | 2019-2024 | Collagenase Santyl, Grafix |
| Biotissue Holdings INC. | $1,009.13 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $698.79 | 2019-2025 | Jublia |
| Treace Medical Concepts, INC. | $421.55 | 2021-2023 | |
| Stryker Corporation | $307.54 | 2022-2025 | Actishield, Flexband, Pro-Toe |
| Osiris Therapeutics INC. | $226.92 | 2019 | |
| Paragon 28, INC. | $142.28 | 2019-2025 | Hammertube Sterile Implant Kits |
| Organogenesis INC. | $119.68 | 2021-2024 | Puraply |
| Bard Peripheral Vascular, INC. | $56.96 | 2021 | |
| Evolution Surgical, INC | $30.95 | 2024 | |
| Kci USA, INC. | $30.29 | 2019 | |
| Arthrosurface Incorporated | $27.81 | 2019 | |
| Ethicon US, LLC | $24.36 | 2022 | |
| Horizon Therapeutics Plc | $23.08 | 2019 | |
| Bioventus LLC | $19.65 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $18.71 | 2025 | |
| Globus Medical, INC. | $18.44 | 2025 | Senza |
| Zyla Life Sciences, INC. | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaveh Akhbari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.